AstraZeneca (AZN) and Alteogen have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme platform ...

To leverage Alteogen's ALT-B4 Hybrozyme platform technology for large volume subcutaneous administration of drugs.

Licensing allows startups to generate capital, leverage industry expertise, and gain market intelligence—all while keeping ...

Midnight Rodeo, a Springfield, Missouri bar, finds itself at the center of a federal lawsuit alleging unauthorized use of ...

Ovanti has inked a licensing agreement with BNPLPay Protocol, a blockchain-based lending platform tailored for the buy now, ...

FRANKLIN, TENNESSEE / ACCESS Newswire / March 12, 2025 / Logo Brands, Inc. is proud to announce the renewal of its licensing ...

How does the expiration of the patents in one jurisdiction impact global royalty payments? This question was addressed by the ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Ono Pharmaceutical Co., Ltd (Ono), today announced that the two companies have ...

With the global downturn in certain asset class valuations, hotels are experiencing something of a renaissance and have re-emerged as a ...

Yesterday, the UK’s High Court of Justice of England and Wales (EWHC) issued an approved judgment ruling on the scope of a ...